Silvadene



Indications and Reactions:

Role Indications Reactions
Primary
Thermal Burn 26.5%
Asthma 5.9%
Breast Cancer 5.9%
Hypertension 5.9%
Localised Infection 5.9%
Pain 5.9%
Sepsis 5.9%
Type 2 Diabetes Mellitus 5.9%
Cellulitis 4.4%
Post Procedural Infection 4.4%
Bone Marrow Failure 2.9%
Decubitus Ulcer 2.9%
Multiple Sclerosis 2.9%
Premedication 2.9%
Rash 2.9%
Systemic Lupus Erythematosus 2.9%
Burns Third Degree 1.5%
Drug Use For Unknown Indication 1.5%
Epidermolysis Bullosa 1.5%
Infection 1.5%
Skin Discolouration 21.1%
Drug Effect Decreased 7.9%
Application Site Discolouration 5.3%
Drug Hypersensitivity 5.3%
Eye Irritation 5.3%
Skin Exfoliation 5.3%
Skin Injury 5.3%
Skin Ulcer 5.3%
Urticaria 5.3%
Vomiting 5.3%
Wrong Technique In Drug Usage Process 5.3%
Argyria 2.6%
Blister 2.6%
Insomnia 2.6%
Maternal Exposure During Pregnancy 2.6%
Off Label Use 2.6%
Skin Disorder 2.6%
Skin Necrosis 2.6%
Sunburn 2.6%
Therapeutic Response Unexpected 2.6%
Secondary
Drug Use For Unknown Indication 16.7%
Localised Infection 16.7%
Sepsis 12.1%
Asthma 9.1%
Multiple Sclerosis 8.3%
Hypertension 6.8%
Post Procedural Infection 6.8%
Systemic Lupus Erythematosus 5.3%
Premedication 4.5%
Product Used For Unknown Indication 3.0%
Acute Lymphocytic Leukaemia 2.3%
Febrile Neutropenia 1.5%
Pain 1.5%
Drug Toxicity 0.8%
Epidermolysis Bullosa 0.8%
Gastrointestinal Haemorrhage 0.8%
Nausea 0.8%
Ph Urine Abnormal 0.8%
Pharyngitis Streptococcal 0.8%
Pulmonary Arterial Hypertension 0.8%
Systemic Lupus Erythematosus 22.7%
Transaminases Increased 18.2%
Drug Hypersensitivity 13.6%
Argyria 4.5%
Diarrhoea 4.5%
Insomnia 4.5%
Muscle Twitching 4.5%
Rash 4.5%
Skin Ulcer 4.5%
Stomatitis 4.5%
Synovial Cyst 4.5%
Treatment Failure 4.5%
Wound 4.5%
Concomitant
Product Used For Unknown Indication 29.2%
Drug Use For Unknown Indication 13.3%
Pain 9.4%
Breast Cancer 7.0%
Medical Diet 4.8%
Anxiety 4.7%
Non-small Cell Lung Cancer 4.1%
Nausea 3.6%
Depression 2.9%
Prophylaxis 2.8%
Diarrhoea 2.5%
Anaemia 2.3%
Headache 2.2%
Attention Deficit/hyperactivity Disorder 1.9%
Hypertension 1.9%
Thrombocytopenia 1.8%
Rheumatoid Arthritis 1.6%
Constipation 1.4%
Fatigue 1.3%
Multiple Allergies 1.3%
Vomiting 12.2%
Wound Complication 12.2%
Thrombocytopenia 9.8%
Wound Infection 8.5%
White Blood Cell Count Decreased 6.1%
Drug Effect Decreased 4.9%
Skin Ulcer 4.9%
Staphylococcal Infection 4.9%
Disease Progression 3.7%
Pain 3.7%
Thermal Burn 3.7%
Transfusion Reaction 3.7%
Upper Respiratory Tract Infection 3.7%
Weight Increased 3.7%
Accidental Overdose 2.4%
Arthralgia 2.4%
Bronchitis 2.4%
Dyspnoea 2.4%
Fatigue 2.4%
Infection 2.4%